...
首页> 外文期刊>JK Science : Journal of Medical Education & Research >Comparative Adverse Drug Profile of Deflazacort Vs Conventional Corticosteroids in Spontaneous Reporting System of Pharmacovigilance
【24h】

Comparative Adverse Drug Profile of Deflazacort Vs Conventional Corticosteroids in Spontaneous Reporting System of Pharmacovigilance

机译:自发性药物警戒报告系统中Deflazacort与常规皮质类固醇的不良药物比较

获取原文
           

摘要

The current observational cross-sectional study was undertaken using suspected adverse drug data collection form available under (PvPI) to evaluate comparative ADR profile of DFZ Vs CCS for 3 years in spontaneous reporting system of ADRs in current PvPI. Total number of ADR reports during the study period was 3024, out of which ADRs reports due to CS were 112 accounting for a rate of 3.70%. The rate of total ADR events with CS was 4.11%. Geriatric, urban and female population predominated in contributing ADRs with both CCS and DFZ in the study. Self medication of CCS and DFZ contributed 10.95% and 7.69% of total ADRs. Oral route contributed maximal ADRs. Irrational drug prescription contributed substantially. Maximum ADRs due to CCS and DFZ were moderate, latent, non-serious, type A and were probable followed by possible in nature as per WHO UMC scale. Gastritis, new onset hypertension/ loss of hypertensive control, loss of diabetic control, obesity/overweight, dyslipedemia were common ADRs. Thus, ADRs due to CS is a substantial health problem. ADR profile did not vary although DFZ recorded less ADRs.
机译:本观察性横断面研究使用(PvPI)下提供的疑似不良药品数据收集表进行,以评估在当前PvPI自发ADR报告系统中DFZ Vs CCS的比较ADR概况3年。研究期间的ADR报告总数为3024,其中CS导致的ADR报告为112,占3.70%。伴有CS的总ADR事件发生率为4.11%。在这项研究中,老年人,城市和女性人口在贡献ADR方面占主导地位。 CCS和DFZ的自我药物治疗分别占ADR的10.95%和7.69%。口服途径贡献了最大的ADR。不合理的药物处方贡献很大。 CCS和DFZ造成的最大ADR为中度,潜伏,非严重,A型,并且根据WHO UMC等级,其本质上可能是可能的。常见的ADR为胃炎,新发高血压/失去高血压控制,失去糖尿病控制,肥胖/超重,血脂异常。因此,由于CS引起的ADR是一个严重的健康问题。尽管DFZ记录的ADR较少,但ADR的配置文件却没有变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号